| Synonyms | KLK-13, KLKL-4, KLKL4, Kallikrein-like protein 4, KLK-L4, FocusOn006 |
| Swiss Prot Num | Q9UKR3 |
| Immunogen | This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human KLK13. |
| Product Type | Antibodies |
| Storage | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| References | 1. Kapadia, C., et al., Biochem. Biophys. Res. Commun. 323(3):1084-1090 (2004). 2. Petraki, C.D., et al., Prostate Cancer Prostatic Dis. 6(3):223-227 (2003). 3. Chang, A., et al., Br. J. Cancer 86(9):1457-1464 (2002). 4. Chang, A., et al., Anticancer Res. 21(5):3147-3152 (2001). 5. Diamandis, E.P., et al., Trends Endocrinol. Metab. 11(2):54-60 (2000). |
|
| Format | State: Liquid purified Ig |
| ? | Purification: Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS |
| ? | Buffer System: PBS with 0.09% (W/V) sodium azide |
|
| Specificity | This antibody reacts to Kallikrein 13 (KLK13). |
| Application | ELISA: 1/1,000. Western Blot. |
| Background | Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. Expression of KLK13 is regulated by steroid hormones and may be useful as a marker for breast cancer. |
| Caution | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Concentration | 0.25 mg/ml |
| Focuson | 006 Antibodies to Kallikrein Family |
